Radiofrequency Ablation for the Palliative Treatment of Osseous Metastases:
Final Results from a Multicenter Study (OPuS One)
Plenary Session - Abstract Of The Year
Wednesday, March 24
11:00 a.m.-12:00 p.m ET
Improvement in Quality of Life in Patients Treated for Painful Osseous Metastases with Radiofrequency Ablation:
The OPuS One Study
Concurrent Sessions: MSK Interventions/Pediatric IR
Friday, March 26
10:00-11:00 a.m. ET
Osteocool™ radiofrequency ablation
OPuS One - The largest prospective study on the performance and safety of RFA for the treatment of palliative bone metastases to date.
Attend our abstracts and symposium for more information.